Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Bausch & Lomb Corp (BLCO)
Bausch & Lomb Corp (BLCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Bausch + Lomb and Novaliq Announce Publication of Second Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in American Journal of Ophthalmology

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Novaliq GmbH, a biopharmaceutical company...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2022 Results

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”, “we” or “our”), a leading global eye health company dedicated to helping people see better to live better,...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb Appoints Brent Saunders as Chief Executive Officer and Chair of the Board of Directors, Effective March 6, 2023

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, announced the appointment...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
New Bausch + Lomb Social Media Campaign Highlights What ‘Sights’ Inspire AMD Patients

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced a new social media campaign...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb’s VISUDYNE® (Verteporfin for Injection)

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Modulight Corporation (“Modulight”),...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb Acquires AcuFocus, Inc.

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and AcuFocus, Inc. (“AcuFocus”), a privately...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of PreserVision...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb Publishes Update Presentation for the 41st Annual J.P. Morgan Healthcare Conference

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, has published a company...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)
Bausch + Lomb Announces Participation at the 41st Annual J.P. Morgan Healthcare Conference

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced that Joseph C. Papa, chief...

BLCO : 16.84 (+0.30%)
BLCO.TO : 22.93 (+0.44%)

Barchart Exclusives

The X-Factor that Could Trigger a Gold Boom in the 2nd Half of 2023
Gold prices jumped to $2,000 last week in the wake of the collapse of Silicon Valley Bank. However, this could be just the start of a higher move for the precious metal. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar